3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Conditions
Ovarian Neoplasms
33
Uterine Cervical Neoplasms
29
Endometrial Neoplasms
23
Breast Neoplasms
11
Fallopian Tube Neoplasms
7
Vulvar Neoplasms
6
Uterine Neoplasms
6
Carcinoma, Ovarian Epithelial
6
Colorectal Neoplasms, Hereditary Nonpolyposis
5
Colorectal Neoplasms
5
Colonic Neoplasms
5
Vaginal Neoplasms
4
Neoplasms
4
Uterine Cervical Dysplasia
3
Rectal Neoplasms
3
Prostatic Neoplasms
3
Pelvic Neoplasms
3
Hereditary Breast and Ovarian Cancer Syndrome
3
Vomiting
2
Urinary Bladder Neoplasms
2
Sarcoma
2
Obesity
2
Nausea
2
Motor Activity
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Lymphedema
2
Leukemia
2
Kidney Neoplasms
2
Gynecologic Cancer
2
Interventions
Oxaliplatin
2
Mitomycin
2
Leucovorin
2
Hyperthermic Intraperitoneal Chemotherapy
2
Surveys and Questionnaires
1
Standard of Care
1
Specimen Handling
1
Referral and Consultation
1
Radiosurgery
1
Psychiatric Rehabilitation
1
Pharmacogenomic Testing
1
Observation
1
Nivolumab
1
Methods
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Ifosfamide
1
Gemcitabine
1
Fluorouracil
1
Floxuridine
1
Early Intervention, Educational
1
Doxorubicin
1
Cisplatin
1
Carboplatin
1
CTLA-4 Antigen
1
Behavior Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pseudomyxoma Peritonei
×
Surveys and Questionnaires
×
Gynecologic
×
Clear all
NCT01126346
2018-07-03
HOPE
Wake Forest University Health Sciences
Phase NA
Completed
10 enrolled